VolitionRx Demonstrates NuQ Blood Test Detects 95% of Pancreatic Cancers in Second Preliminary Study - Introduction to VolitionRx Nucleosomics technology: Revolutionizing cancer diagnosis
b'VolitionRx\\ufffds Nucleosomics\\ufffd diagnostic platform detects epigenetic changes to fragments of chromosomes, called nucleosomes, that circulate in the blood of cancer patients. Credit: VolitionRx.'